Volatile pot stock still worth holding

Article Excerpt

TILRAY INC. $214 (Nasdaq symbol TLRY; Manufacturing sector; Shares outstanding: 93.4 million; Market cap: $20.0 billion; No dividends paid; Takeover Target Rating: Medium; www.tilray.com) is a Canadian medical marijuana producer, which began operating in 2013. The company sold 10.35 million common shares at $17.00 a share U.S. through an initial public offering on July 19, 2018. Since then the stock has shot up over 1,155%. The gain is partly because Tilray is one of only a few cannabis producers listed on a major U.S. exchange. Speculation that a large beverage maker will buy a stake in the company has also fueled the price jump. Constellation Brands and Molson Coors have already partnered with other large cannabis producers. Those beverage giants expect legalized marijuana to hurt alcohol demand and are anxious to develop cannabis-infused drinks. Further contributing to Tilray’s jump, the company has now won approval to supply marijuana for a clinical trial at the University of California San Diego. That study aims to develop a..